Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
As the year draws to a close, it’s time to recall the biggest stories from the FCPA Blog. Here are my choices for the top five stories we’ve covered during 2022, along with some personal favorites for honorable mention.… Continue Reading
New and old corporate dishonesty stories, such as Theranos, Wirecard, and Wells Fargo, highlight a fundamental weakness. Irrespective of the industry or the business maturity, the wrongdoing escalates when the lines of defense that should protect the organization from risk become Teflon barriers to any accountability process.… Continue Reading
The current troubles at McDonald’s Corp. — involving allegations that former CEO Steve Easterbrook had improper relationships with several employees, and that he and the HR department engaged in a mutual cover-up of improprieties — have again revealed how corporate boards are often overwhelmed by charismatic and strong-willed CEOs.… Continue Reading
During most interviews, I’m asked this question or something like it: More companies than ever have compliance programs. Yet huge scandals keep making headlines. What gives?
To be fair, there’s plenty of evidence that compliance has failed: Volkswagen cheated on diesel emissions tests.… Continue Reading
Elizabeth Holmes of TheranosThe DOJ Friday charged the founder of Theranos Inc. and the company’s former chief operating officer with defrauding investors, doctors, and patients with phony claims about supposedly disruptive blood-testing technology.… Continue Reading
Elizabeth Holmes of TheranosTheranos Inc. — once the most valuable medical technology start up in America — is now a slow-motion corporate disaster generating waves of bad news.
It’s a corporate disaster that didn’t need to happen.… Continue Reading
Everyone knows that “tone at the top” is important in the ethics and compliance area but the phrase has become a tired and hackneyed cliché. The recent public implosions of established companies and start-ups however, add a fresh perspective and meaning to the concept by illustrating what happens when a CEO or C-suite sets a toxic tone at the top.… Continue Reading
